Ambulatory blood pressure monitoring in patients with chronic kidney disease and resistant hypertension

Journal of Clinical Hypertension

Volumn 14, Issue 9, 2012, Pages 611-617

  Shafi, Salman ^a,b   Sarac, Erdal ^a,b   Tran, Huy ^a  

^a ST ELIZABETH HEALTH CENTER   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LOOP DIURETIC AGENT; RENIN INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUSTAINED HYPERTENSIO; SUSTAINED HYPERTENSION; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; WHITE COAT HYPERTENSION;

EID: 84865757777     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00675.x     Document Type: Article

References (37)

1. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:1-290.
2. Sarafidis PA, Li S, Chen S-C, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121:332-340.
3. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45:994-1001.
4. Kuriyama S, Otsuka Y, Iida R, et al. Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy. Intern Med. 2005;44:1239-1246.
5. Kuriyama S, Otsuka Y, Iida R, et al. Morning blood pressure at home predicts erythropoietin induced hypertension in patients with chronic renal diseases. Clin Exp Nephrol. 2007;11:66-70.
6. Minutolo R, Borrelli S, Scigliano R, et al. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease. Nephrol Dial Transplant. 2007;22:2217-2223.
7. Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2009;4:656-664.
8. Pogue V, Rahman M, Lipkowitz M, et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53:20-27.
9. Agarwal R. Home and ambulatory blood pressure monitoring in chronic kidney disease. Curr Opin Nephrol Hypertens. 2009;18:507-512.
10. De Nicola L, Borrelli S, Gabbai FB, et al. Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease. Kidney Blood Press Res. 2011;34:58-67.
11. De la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898-902.
12. Muxfeldt ES, Bloch KV, Nogueira Ada R, et al. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18:1534-1540.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
14. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-1419.
15. Goodwin J, Bilous M, Winship S, et al. Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood Press Monit. 2007;12:113-117.
16. O'Brien E, Asmar R, Beilin L, et al. On behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848.
17. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716.
18. Bonso E, Ragazzo F, Palatini P. Validation of A&D UA-85X device for blood pressure measurement. Blood Press Monit. 2008;13:339-341.
19. Tomlinson LA, Holt SG, Leslie AR, et al. Prevalence of ambulatory hypotension in elderly patients with CKD stages 3 and 4. Nephrol Dial Transplant. 2009;24:3751-3755.
20. Vokó Z, Bots ML, Hofman A, et al. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension. 1999;34:1181-1185.
21. Somes GW, Pahor M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004-2009.
22. Shorr RI, Somes GW. Can disastolic blood pressure be excessively lowered in the treatment of isolated systolic hypertension? J Clin Hypertens. 2000;2:134-137.
23. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884-893.
24. Boutitie F, Gueyffier F, Pocock S, et al. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med. 2002;136:438-448.
25. Protogerou AD, Safar ME, Iaria P, et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension. 2007;50:172-180.
26. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, et al. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006;21:1257-1262.
27. Berl T, Hunsicker LG, Lewis JB, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16:2170-2179.
28. Weiner DE, Tighiouart H, Levey AS, et al. Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol. 2007;18:960-966.
29. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med. 2002;347:1256-1261.
30. Jafar TH, Stark PC, Schmid CH. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244-252.
31. Peralta CA, Shlipak MG, Wassel-Fyr C, et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension. 2007;50:474-480.
32. Palatini P. Ambulatory blood pressure and cardiovascular risk in chronic kidney disease. Curr Hypertens Rep. 2008;10:119-126.
33. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
34. Agarwal R, Anderson MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:1175-1180.
35. Agarwal R, Anderson MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol. 2006;26:503-510.
36. Upadhyay A, Earley A, Haynes SM, et al. Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med. 2011;154:541-548.
37. Minutolo R, Agarwal R, Borrelli S, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090-1098.